Mankind Pharma Sees Surge in Open Interest Amidst Active Market Participation

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 1,948 contracts, reflecting a rise of 363 contracts or 22.9% from the previous open interest of 1,585. This uptick in open interest comes alongside a trading volume of 1,191 contracts, indicating active participation in the market.
In terms of financial metrics, Mankind Pharma's futures value is reported at Rs 2,678.98 lakhs, while the options value is considerably higher at Rs 4,159.23 lakhs, bringing the total value to Rs 2,753.45 lakhs. The underlying value of the stock is noted at Rs 2,430.

Despite this notable activity, Mankind Pharma's stock has underperformed the sector, showing a 1D return of -1.68%, compared to the sector's -0.13% and the Sensex's -0.35%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. However, the delivery volume has seen a substantial increase of 256.33% against the 5-day average, suggesting rising investor participation.

In summary, Mankind Pharma's notable increase in open interest highlights a shift in market dynamics, while the stock's performance metrics indicate a challenging trading environment.